Idorsia Market Cap

Idorsia has a market cap or net worth of 887.82 million as of March 9, 2026. Its market cap has increased by 494.67% in one year.

Market Cap

887.82M

Enterprise Value

2.07B

Revenue

220.58M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.62

Market Cap Chart

Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 887.82M, a decrease of -45.40%. That is a compound annual growth rate of -6.70%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	887.82M	-16.46%
Dec 30, 2025	1.06B	586.49%
Dec 30, 2024	154.81M	-58.92%
Dec 29, 2023	376.84M	-84.18%
Dec 30, 2022	2.38B	-27.77%
Dec 30, 2021	3.30B	-22.36%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Basilea Pharmaceutica AG	639.16M
Newron Pharmaceuticals	366.19M
Santhera Pharmaceuticals Holding AG	213.08M
BioVersys AG	149.71M
Molecular Partners AG	145.86M
Xlife Sciences AG	127.46M
EvoNext Holdings	6.98M
Addex Therapeutics	5.83M

Market Cap Rankings